Dermatology + Aesthetic Marketing Benchmark India 2026 — CPQL, Channel Mix, Budgets

This is the Dermatology + Aesthetic splinter of ICG's flagship "State of Healthcare Marketing India 2026." Five headline stats. CPQL by city tier. Channel-mix specific to Dermatology + Aesthetic. Budget benchmarks by clinic size. The five most common leaks — and the fix for each. Directional data drawn from ICG's engagement across 150+ healthcare brands, 2024–2026.

Executive summary

Dermatology and aesthetic is the fastest-growing spend category in Indian healthcare marketing (2024–2026). ICG estimates the category has roughly tripled in ad spend since 2022, driven by category expansion (laser, injectables, hair, weight management, wellness) and the split into distinct medical vs cosmetic sub-funnels with different economics.

The single biggest architectural mistake in derm marketing today is running one funnel for both medical and cosmetic derm. Medical derm patients (acne, eczema, alopecia, pigmentation) behave like GP patients — short consideration, high intent, WhatsApp-forward. Cosmetic derm patients (laser, injectables, HIFU, chemical peel) behave like elective surgery patients — long consideration, comparison-heavy, video-persuaded.

CPQL bands: Medical derm ₹550–₹950 (metro), Aesthetic derm ₹850–₹1,600 (metro). The market median for aesthetic derm has risen ~55% since 2022, partly because CPMs have risen and partly because consideration cycles have lengthened as the category has matured and patients now comparison-shop across 4–7 clinics.

Instagram is now the primary discovery surface for aesthetic derm — Meta remains the biggest media channel, but Instagram creator content, Reels, and DM-to-WhatsApp handoff carry more of the actual conversion journey than the raw ads themselves. The clinics winning in 2026 built creator + doctor content libraries in 2024–25.

Five stats to sanity-check your Dermatology + Aesthetic programme

CPQL by city — metro, T2, T3

CPQL (Cost Per Qualified Lead) for Dermatology + Aesthetic varies materially by city tier because competition density, CPMs, and consideration cycles all move together. Use the table below as a directional sanity check for your account.

Q2 2026 refresh. CPQL = monthly media spend ÷ attended first consultations. Rolling 90-day medians. Individual clinic results vary by competition density, brand maturity, and adherence to operating model.

Channel mix — what works for Dermatology + Aesthetic

The channel-mix table below is ICG's specialty-specific weighting for Dermatology + Aesthetic — not the blended-portfolio average from the flagship. Where a specialty over- or under-indexes on a channel, we call out why.

Budget benchmarks by clinic size

What a well-run Dermatology + Aesthetic programme spends monthly, by clinic size. Numbers are total marketing spend (media + retainer), not media-only.

Five most common leaks in Dermatology + Aesthetic — and the fix

Every year ICG audits ~40 healthcare accounts before onboarding. In Dermatology + Aesthetic specifically, five leaks appear over and over. Each one is worth 20–50% CPQL reduction on its own.

Inside the ICG operating model for Dermatology + Aesthetic

ICG runs derm and aesthetic as two separate operating models, not one. The medical-derm side looks like GP marketing — GMB primary, WhatsApp inbound, 4-minute first response, review velocity. The aesthetic side looks like plastic-surgery marketing — video-led, creator-content assisted, 7-touch WhatsApp nurture, longer consideration cycle, higher touchpoint count, higher CPQL, higher pLTV.

Splitting them at the campaign level, at the landing-page level, at the CRM segmentation level, and at the reporting level is the architectural fix that separates ICG-portfolio derm clinics from market-median performance. The clinics doing this well are 40–60% below market CPQL on aesthetic and 25–35% below on medical.

Frequently asked — about Dermatology + Aesthetic marketing in India, 2026

What is a good CPQL for aesthetic dermatology in India in 2026?

ICG median across metros is ₹950 (Q2 2026). Market median is ₹1,400. The gap comes from four architectural fixes: two-funnel split (medical vs cosmetic), 7-touch WhatsApp nurture, doctor + creator content library, and CAPI EMQ ≥7. Any aesthetic-derm CPQL above ₹1,600 in a metro almost certainly has three or more of the five leaks above.

What is a good CPQL for medical dermatology?

Medical derm behaves like GP — high intent, short consideration, high attendance rate (66% ICG median). CPQL band ₹550–950 metros, ₹380–780 T2. If your medical-derm CPQL is above ₹1,100 in a metro you are almost certainly running Meta-only when GMB + WhatsApp would deliver at less than half the cost.

Should a derm clinic invest in influencer / creator content?

For aesthetic derm — yes, with mandatory NMC Section 6 compliance scaffolding on every asset. Budget cap 12–14% of total marketing. Written legal review per creator per asset. No outcome claims. Doctor co-appearance materially lifts trust and conversion. Skipping this in aesthetic 2026 means ceding discovery share to clinics that don't.

How much should a solo dermatologist spend on marketing per month?

Directional band: ₹80k – ₹2L per month total (media + retainer). Weighted Meta 42% · GMB 18% · Google 14% · creator 10% · WhatsApp 8% · SEO 8%. Solo dermatologists routinely overspend Meta and underspend GMB, which is the primary leak on a small budget.

What is the typical pLTV for aesthetic derm patients?

Directional ICG portfolio pLTV: single-treatment aesthetic patient ₹9k – ₹22k; multi-treatment package patient ₹35k – ₹85k; retained aesthetic patient (24-month) ₹80k – ₹1.8L. pLTV is why a ₹1,600 CPQL can still be highly profitable — but only if the clinic operationalises retention beyond first treatment.